Chiron licenses Comedicus pericardial access device
This article was originally published in Clinica
Executive Summary
Chiron is to have an exclusive licence to the Comedicus pericardial access device for drug delivery for a total of $3 million. Under the agreement, US company Chiron will loan privately-owned Comedicus funds for further development, testing and commercialisation of its PerDucer device.